Claudine Rancourt

4.5k total citations
59 papers, 3.6k citations indexed

About

Claudine Rancourt is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Claudine Rancourt has authored 59 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 22 papers in Immunology and 18 papers in Genetics. Recurrent topics in Claudine Rancourt's work include Virus-based gene therapy research (16 papers), Cell death mechanisms and regulation (15 papers) and Galectins and Cancer Biology (9 papers). Claudine Rancourt is often cited by papers focused on Virus-based gene therapy research (16 papers), Cell death mechanisms and regulation (15 papers) and Galectins and Cancer Biology (9 papers). Claudine Rancourt collaborates with scholars based in Canada, United States and Taiwan. Claudine Rancourt's co-authors include Alain Piché, Isabelle Matte, Denis Lane, Martine Migneault, Manish S. Patankar, Jennifer A. Belisle, Joseph P. Connor, Claude Laplante, Jennifer A. A. Gubbels and David T. Curiel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Claudine Rancourt

58 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudine Rancourt Canada 33 2.2k 1.0k 964 681 570 59 3.6k
Barry M. Kacinski United States 40 1.6k 0.8× 1.3k 1.2× 1.2k 1.3× 652 1.0× 444 0.8× 94 4.1k
Tapan K. Bera United States 34 1.5k 0.7× 1.0k 1.0× 1.0k 1.1× 340 0.5× 195 0.3× 87 3.6k
Burkhard Helmke Germany 28 1.3k 0.6× 897 0.9× 418 0.4× 237 0.3× 330 0.6× 78 2.9k
Alberto Gallardo Spain 28 1.1k 0.5× 822 0.8× 394 0.4× 194 0.3× 494 0.9× 70 2.4k
Timothy K. Starr United States 24 1.9k 0.9× 874 0.8× 1.4k 1.4× 386 0.6× 77 0.1× 67 3.6k
Jerald J. Killion United States 25 1.5k 0.7× 1.2k 1.2× 450 0.5× 217 0.3× 157 0.3× 68 3.1k
Brian Gliniak United States 16 3.0k 1.4× 1.5k 1.4× 2.8k 2.9× 482 0.7× 86 0.2× 23 5.6k
Hung‐Cheng Lai Taiwan 37 2.7k 1.3× 1.4k 1.4× 275 0.3× 182 0.3× 427 0.7× 88 4.2k
Xin He China 27 1.3k 0.6× 456 0.4× 500 0.5× 230 0.3× 142 0.2× 132 2.4k
Raquel Almeida Portugal 34 2.6k 1.2× 632 0.6× 833 0.9× 649 1.0× 53 0.1× 81 3.8k

Countries citing papers authored by Claudine Rancourt

Since Specialization
Citations

This map shows the geographic impact of Claudine Rancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudine Rancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudine Rancourt more than expected).

Fields of papers citing papers by Claudine Rancourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudine Rancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudine Rancourt. The network helps show where Claudine Rancourt may publish in the future.

Co-authorship network of co-authors of Claudine Rancourt

This figure shows the co-authorship network connecting the top 25 collaborators of Claudine Rancourt. A scholar is included among the top collaborators of Claudine Rancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudine Rancourt. Claudine Rancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matte, Isabelle, Perrine Garde‐Granger, Claude Laplante, et al.. (2016). Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Clinical & Experimental Metastasis. 33(8). 839–852. 34 indexed citations
2.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2016). CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Molecular Cancer. 15(1). 58–58. 57 indexed citations
3.
Matte, Isabelle, Denis Lane, Dimcho Bachvarov, Claudine Rancourt, & Alain Piché. (2014). Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer. 14(1). 288–288. 31 indexed citations
4.
Matte, Isabelle, Denis Lane, Marianne Boivin, Claudine Rancourt, & Alain Piché. (2014). MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression. BMC Cancer. 14(1). 234–234. 31 indexed citations
5.
6.
Lane, David P., et al.. (2010). The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells. Oncogene. 29(40). 5523–5536. 50 indexed citations
7.
Venables, Julian P., Roscoe Klinck, ChuShin Koh, et al.. (2009). Cancer-associated regulation of alternative splicing. Nature Structural & Molecular Biology. 16(6). 670–676. 281 indexed citations
8.
Belisle, Jennifer A., Jennifer A. A. Gubbels, Martine Migneault, et al.. (2009). Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies. Journal of Ovarian Research. 2(1). 8–8. 16 indexed citations
9.
Venables, Julian P., Roscoe Klinck, Anne Bramard, et al.. (2008). Identification of Alternative Splicing Markers for Breast Cancer. Cancer Research. 68(22). 9525–9531. 140 indexed citations
10.
Klinck, Roscoe, Anne Bramard, Lyna Inkel, et al.. (2008). Multiple Alternative Splicing Markers for Ovarian Cancer. Cancer Research. 68(3). 657–663. 122 indexed citations
11.
Garneau, Hugo, Carine Lussier, Claudine Rancourt, et al.. (2007). Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(4). G758–G772. 11 indexed citations
12.
Pagé, Viviane, et al.. (2005). BAG-1 p29 protein prevents drug-induced cell death in the presence of EGF and enhances resistance to anoikis in SKOV3 human ovarian cancer cells. Biochemical and Biophysical Research Communications. 328(4). 874–884. 17 indexed citations
13.
Lane, David P., et al.. (2004). Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Gynecologic Oncology. 93(3). 594–604. 51 indexed citations
14.
Rancourt, Claudine, et al.. (2004). Quantitative Assessment of Human Endometriotic Tissue Maintenance and Regression in a Noninvasive Mouse Model of Endometriosis. Molecular Therapy. 9(4). 540–547. 27 indexed citations
15.
16.
Piché, Alain & Claudine Rancourt. (2001). Gene Therapy to Overcome Drug Resistance in Cancer: Targeting Key Regulators of the Apoptotic Pathway. Current Gene Therapy. 1(4). 317–324. 5 indexed citations
17.
Piché, Alain & Claudine Rancourt. (1999). A role for intracellular immunization in chemosensitization of tumor cells?. Gene Therapy. 6(7). 1202–1209. 5 indexed citations
18.
Rancourt, Claudine, Matthew Robertson, C. Goldman, et al.. (1998). Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary.. PubMed. 4(2). 265–70. 27 indexed citations
19.
Rancourt, Claudine. (1997). Conditionally replicative adenoviruses for cancer therapy. Advanced Drug Delivery Reviews. 27(1). 67–81. 12 indexed citations
20.
Rancourt, Claudine, et al.. (1994). Identification of active-site residues of the adenovirus endopeptidase.. Proceedings of the National Academy of Sciences. 91(3). 844–847. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry M. Kacinski Breakdown of academic impact, for papers by Tapan K. Bera Breakdown of academic impact, for papers by Burkhard Helmke Breakdown of academic impact, for papers by Alberto Gallardo Breakdown of academic impact, for papers by Timothy K. Starr Breakdown of academic impact, for papers by Jerald J. Killion Breakdown of academic impact, for papers by Brian Gliniak Breakdown of academic impact, for papers by Hung‐Cheng Lai Breakdown of academic impact, for papers by Xin He Breakdown of academic impact, for papers by Raquel Almeida
Rankless by CCL
2026